Chemicals and pharmaceuticals

CTI BIOPHARMA CORP

12 filings mentioning 8 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
8topics disclosed
Chemicals and pharmaceuticalsindustry
WAbased in

Across 12 filings we hold, CTI BIOPHARMA CORP has written down 8 of the topics we track. That places it 10 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

CB Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something CTI BIOPHARMA CORP has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO 27001:202242
ISO 37001:201639
ISO 22301:201938
ASD Strategies to Mitigate Cyber Security Incidents29
GDPR26
ISO 3700126
ISO/IEC 27701:201921
Code of Conduct on Data Protection for Research (GDPR Article 40)12
HIPAA Security Rule10

10 frameworks, 321 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Business Continuity10
Internal Control3
Restatement2
Ransomware2
Regulatory Reporting1
Data Breach1
Enforcement Action1
Material Weakness1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Business Continuity102023-03-06
Internal Control32021-04-06
Restatement22021-01-15
Ransomware22023-05-10
Regulatory Reporting12021-11-12
Data Breach12023-05-10
Enforcement Action12023-05-10
Material Weakness12023-05-10

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23

Recent filings

FiledFormItem
2023-05-108-KEntry into a material agreement, Item 5.03, Other material eventfiling
2023-03-0610-Kfiling
2022-03-3110-Kfiling
2021-11-1210-Qfiling
2021-04-068-KEntry into a material agreement, Item 5.03, Financial statements and exhibitsfiling
2021-03-1710-Kfiling
2021-01-158-KEntry into a material agreement, Financial statements and exhibitsfiling
2020-11-1010-Qfiling
2020-05-1510-Qfiling
2020-03-1310-Kfiling
2019-11-158-KEntry into a material agreement, Financial statements and exhibitsfiling
2019-11-0410-Qfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition